Skip to content

Thulium Fiber Laser Prospective Trial

Prospective Clinical Trial To Evaluate The Thulium Fiber Laser For The Ureteroscopic Treatment Of Nephrolithiasis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05814133
Acronym
TFL
Enrollment
150
Registered
2023-04-14
Start date
2024-01-15
Completion date
2025-07-15
Last updated
2024-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone

Keywords

ureteroscopy, lithotripsy, thulium fiber laser

Brief summary

This is a multi-center, prospective clinical trial to assess the effect of TFL for the lithotripsy of kidney stones.

Detailed description

Flexible ureteroscopy is considered the first-line therapy for renal stones \< 2 cm. The Holmium: YAG laser (Ho:YAG) is established as gold standard in urology practice. Despite its limitations, it is widely used to break stones into fragments small enough to remove or pass spontaneously through the ureter. Advances in the understanding of laser energy delivery have led to the recent commercialization of the 'Thulium Fiber Laser' (TFL) with unique characteristics and promising improvements of ablation efficiency, dusting capacity, operating time and deflection. A a multi-center, prospective clinical trial to further assess those advantages for the lithotripsy of kidney stones will be conducted.

Interventions

Thulium Fiber Laser will be used to break renal stones \< 2 cm into fragments small enough to remove or pass spontaneously through the ureter.

Sponsors

University of British Columbia
CollaboratorOTHER
Columbia University
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Ohio State University
CollaboratorOTHER
Vanderbilt University
CollaboratorOTHER
The Cleveland Clinic
CollaboratorOTHER
Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Solitary renal stone 8 to 20 mm in size or in the case of multiple stones the conglomerate diameter of 8-20 mm is required * Must be a suitable operative candidate for flexible ureteroscopy per urologic guidelines * Must be 18 years or older * Must be able to give consent * Bilateral ureteroscopy will be permitted but only the first side will be included in the study

Exclusion criteria

* Concomitant stones in the ureter * Prior ipsilateral upper urinary tract reconstructive procedures or history of ipsilateral ureteral stricture * Prior radiotherapy to the abdomen or pelvis * Neurogenic bladder or spinal cord injury * Pregnancy * Untreated Urinary Tract Infection (UTI)

Design outcomes

Primary

MeasureTime frameDescription
Mean total operative timeduring the procedureTotal operative time during the ureteroscopic treatment of renal stones using a laser dusting technique.

Secondary

MeasureTime frameDescription
Rate of stone retropulsionduring the procedureReview of the procedure video recording to assess stone retropulsion occurence during stone lithotripsy

Other

MeasureTime frameDescription
Rate of need for ancillary proceduresat 6 weeksMedical chart review will be done to assess the occurence of an additional ureteroscopy need to treat patients
Rate of postoperative complicationsat 6 weeksMedical chart review will be done to assess the occurence of post-operative complications
Mean perceived workload scoreimmediately after the procedureEffects of TFL technology on reducing surgeon perceived workload will be assessed by completing the National Aeronautics and Space Administration (NASA) Task Load Index. The tool allows to determine the subjective mental workload (MWL) of a participant while they are performing a task.The participants self-rate on a scale of 1 (low) to 20 (high). The higher the score, the worst is the outcome.
Mean length of hospitalizationFrom day and time of admission to day and time of dischargeLength of hospitalization (in days) for the procedure will be recorded for each patient
Rate of stone free statusat 6 weeksPost-operative CT imaging will be reviewed to assess the occurence of ''stone free status''

Countries

Canada

Contacts

Primary ContactNaeem Bhojani, M.D
naeem.bhojani@gmail.com5148908000
Backup ContactKahina Bensaadi, DESS
kahina.bensaadi.chum@ssss.gouv.qc.ca5148908000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026